# Spironolactone in Patients With Single Ventricle Heart

> **NCT00211081** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 12 (actual)

## Conditions studied

- Congenital Disorders

## Interventions

- **DRUG:** Spironolactone (drug)

## Key facts

- **NCT ID:** NCT00211081
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211081, "Spironolactone in Patients With Single Ventricle Heart". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00211081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*